XML 40 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Schedule of Recurring Measurements
The following financial instruments are remeasured at fair value on a recurring basis:
Fair Value Measurements as of
March 31, 2025December 31, 2024
Cash Flow Hedges: (a) (b)
Level 1Level 2 (c)Level 3Level 1Level 2 (c)Level 3
Derivative interest rate swaps— $10,598 — — $14,426 — 
(a)During the twelve months subsequent to March 31, 2025, an estimated $7,323 of derivative interest rate balances recognized in accumulated comprehensive income will be reclassified into earnings.
(b)As of March 31, 2025 and December 31, 2024, the Company determined that the credit valuation adjustments associated with nonperformance risk are not significant to the overall valuation of its derivatives. As a result, the Company's derivative valuations in their entirety are classified as Level 2 of the fair value hierarchy.
(c)Derivative assets or liabilities are recognized as a part of deferred costs and other assets, net or other liabilities, respectively.
Schedule of Financial Instruments Not Measure at Fair Value
The table below summarizes the estimated fair value of financial instruments presented at carrying values in the Company's condensed consolidated financial statements as of March 31, 2025 and December 31, 2024:
March 31, 2025December 31, 2024
Carrying ValueEstimated 
Fair Value
Market
Interest Rate
Carrying ValueEstimated 
Fair Value
Market
Interest Rate
Mortgages payable$93,380 $88,964 6.33 %$93,380 $87,576 6.64 %
Senior notes250,000 241,540 5.82 %250,000 236,480 6.23 %
Term Loan400,000 400,127 5.00 %400,000 400,170 5.29 %
Revolving Credit Facility— — N/A— — N/A